Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies; ELISA, matched antibody pairs and multiplex immunoassays; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex miRNA assays. Its products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. The company also sells its products online. Abcam plc was founded in 1998 and is based in Cambridge, the United Kingdom.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-1223-696000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£245.40 million
Profitability
Miscellaneous
Employees1,100
Next Earnings DateN/A
OptionableOptionable
Abcam (LON:ABC) Frequently Asked Questions
What is Abcam's stock symbol?
Abcam trades on the London Stock Exchange (LON) under the ticker symbol "ABC."
How often does Abcam pay dividends? What is the dividend yield for Abcam?
Abcam declared a dividend on Monday, March 4th. Shareholders of record on Thursday, March 14th will be given a dividend of GBX 3.55 per share on Friday, April 12th. This represents a yield of 0.32%. The ex-dividend date of this dividend is Thursday, March 14th. The official announcement can be seen at this link. View Abcam's Dividend History.
What price target have analysts set for ABC?
4 brokers have issued twelve-month target prices for Abcam's stock. Their forecasts range from GBX 1,330 to GBX 1,640. On average, they anticipate Abcam's stock price to reach GBX 1,436.67 in the next twelve months. This suggests a possible upside of 31.0% from the stock's current price. View Analyst Price Targets for Abcam.
What is the consensus analysts' recommendation for Abcam?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Abcam in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Abcam.
Has Abcam been receiving favorable news coverage?
Media headlines about ABC stock have trended positive this week, according to InfoTrie. The research group identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Abcam earned a news impact score of 2.1 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days.
Who are some of Abcam's key competitors?
Some companies that are related to Abcam include Cronos Group (CRON), BTG (BTG), MorphoSys (MOR), MorphoSys (MOR), Genus (GNS), Clinuvel Pharmaceuticals (CUV), Concordia International (CXR), Mesoblast (MSB), Resverlogix (RVX), Emerald Health Therapeutics (EMH), Theratechnologies (TH), Biotest (BIO), Polynovo (PNV), Oxford BioMedica (OXB) and Senesco Technologies (ELOX).
What other stocks do shareholders of Abcam own?
Who are Abcam's key executives?
Abcam's management team includes the folowing people:
- Mr. Alan Thomas Hirzel BS, MS, MBA, CEO & Exec. Director (Age 51)
- Dr. Jonathan Simon Milner, Co-Founder & Non-Exec. Deputy Chairman (Age 54)
- Mr. Gavin Hilary James Wood BA (Hons), ACA, CFO & Exec. Director (Age 49)
- James Staveley, VP of Investor Relations
- Ms. Suzanne E. Smith LLB (Hons), MBA, Chief Legal Officer & Company Sec.
How do I buy shares of Abcam?
Shares of ABC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Abcam's stock price today?
One share of ABC stock can currently be purchased for approximately GBX 1,097.
How big of a company is Abcam?
Abcam has a market capitalization of £2.25 billion and generates £245.40 million in revenue each year. Abcam employs 1,100 workers across the globe.
What is Abcam's official website?
How can I contact Abcam?
Abcam's mailing address is 330 Cambridge Science Park, CAMBRIDGE, CB4 0FL, United Kingdom. The company can be reached via phone at +44-1223-696000.
MarketBeat Community Rating for Abcam (LON ABC)
MarketBeat's community ratings are surveys of what our community members think about Abcam and other stocks. Vote "Outperform" if you believe ABC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABC will underperform the S&P 500 over the long term. You may vote once every thirty days.
